Reference
Durham BH, et al. Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms. Blood Advances 7: 7319-7328, No. 23, Dec 2023. Available from: URL: https://dx.doi.org/10.1182/bloodadvances.2022009349
Rights and permissions
About this article
Cite this article
Alpelisib. Reactions Weekly 1995, 20 (2024). https://doi.org/10.1007/s40278-024-53283-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-53283-5